The skin substitute process has made numerous advancements in the field of placental processing, maximizing the rich natural potential that the entire placenta has to offer. Our skin substitute is designed to preserve like no other commercial system. All of the key tissues available for transplant from the placenta, preserve them in their most natural form, and deliver the ultimate range of allograft forms. While various tissue processors may use a similar donated placental tissue source, the resulting quality and performance of a human tissue allograft varies greatly, depending on the processing methods that it undergoes.
The skin substitute process uses new revolutionary technology and sophisticated processing methods to capitalize, so the full potential of the placenta can be utilized like no other company, preserving function and integrity in their natural hydrated state while allowing for improved handling and delivery methods. It has proven safety and quality, surpassing FDA and AATB standards to provide the utmost in patient safety and preservation of native placental tissue allografts transplants.
Placental tissue is an incredibly rich age zero tissue that plays a major role in fetal development as various types of human body tissues develop and mature during gestation. Our skin substitute technology is a unique and state-of-the-art process that preserves these age zero elements of the native human placental tissue. Not all tissue-processing systems are the same, nor do they have the ability to preserve these natural and robust attributes.
The process is a scientifically advanced technology, with numerous innovations in amniotic and placental tissue processing, and has been independently validated to preserve the biologic properties of its tissues. Our industry leading product produces improved tissue forms, delivery options and the broadest indications.
Skin substitute has developed a series of scientific methods to provide a distinct advantage in handling, safety, quality and performance of its products:
- Unique cryo and ambient formulations.
- Industry first room temperature flowable.
- ExCellerate flowable technology- The skin substitute flowable products are a rich biologic Connective Tissue Matrix (CTM). This flowable tissue matrix can be precisely applied to the areas of damaged connective tissue, and provides improved resorption and incorporation for the ideal biologic response.
- The skin substitute technology is designed to protect the biomechanical structure of its membrane tissues, versus other membranes which may be cross-linked or collapsed due to their inferior processing methods.